ondansetron has been researched along with estramustine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Behnam Motlagh, P; Grankvist, K; Henriksson, R | 1 |
Behnam-Motlagh, P; Engström, KG; Grankvist, K; Henriksson, R | 1 |
Behnam-Motlagh, P; Grankvist, K; Henriksson, R; Sandström, PE | 2 |
1 review(s) available for ondansetron and estramustine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for ondansetron and estramustine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interaction of the antiemetics ondansetron and granisetron with the cytotoxicity induced by irradiation, epirubicin, bleomycin, estramustine, and cisplatin in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bleomycin; Cells, Cultured; Cisplatin; Cricetinae; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Epirubicin; Estramustine; Fibroblasts; Granisetron; Humans; Lung Neoplasms; Ondansetron; Serotonin Antagonists; Tumor Cells, Cultured | 1995 |
Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells.
Topics: Cell Size; Drug Combinations; Drug Interactions; Estramustine; Glioma; Granisetron; Humans; Ondansetron; Serotonin; Serotonin Antagonists; Tumor Cells, Cultured | 1999 |
Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport.
Topics: Antiemetics; Antineoplastic Agents; Biological Transport; Bumetanide; Chlorides; Drug Interactions; Estramustine; Granisetron; Humans; K Cl- Cotransporters; Lung Neoplasms; Mesothelioma; Ondansetron; Ouabain; Potassium; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sodium; Sodium-Potassium-Exchanging ATPase; Symporters; Time Factors; Tumor Cells, Cultured | 2001 |
Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Size; Estramustine; Glioma; Granisetron; Humans; Ion Transport; Ondansetron; Potassium; Rubidium Radioisotopes; Serotonin; Serotonin Antagonists; Sodium; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Tumor Cells, Cultured | 2002 |